Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(6 sites)
United States
University of Alabama, Birmingham, Alabama Children's Hospital Orange County, Orange, California University of California San Francisco, San Francisco, California Helen De Vos, Grand Rapids, Michigan New York Medical College, Valhalla, New York Nationwide Children's Hospital, Columbus, Ohio